All data are based on the daily closing price as of April 30, 2026
s

Sunmax Biotechnology

4728.TWO
12.27 USD
-0.05
-0.41%

Overview

Last close
12.27 usd
Market cap
668.31M usd
52 week high
16.58 usd
52 week low
8.23 usd
Target price
N/A usd

Valuation

P/E
29.1573
Forward P/E
N/A
Price/Sales
10.4159
Price/Book Value
13.0791
Enterprise Value
642.12M usd
EV/Revenue
10.0271
EV/EBITDA
18.1112

Key financials

Revenue TTM
64.04M usd
Gross Profit TTM
50.21M usd
EBITDA TTM
33.81M usd
Earnings per Share
0.42 usd
Dividend
0.38 usd
Total assets
67.65M usd
Net debt
N/A usd

About

Sunmax Biotechnology Co., Ltd., a biomedical company, develops, manufactures, and markets biomedical grade collagen and skin care product in Taiwan and Mainland China. The company offers dermal fillers, including Sunmax Deusaderm VITAL and Sunmax Deusaderm LIDO Injectable Collagen Gel with Lidocaine. The company was founded in 2001 and is headquartered in Tainan City, Taiwan.
  • Symbol
    4728.TWO
  • Exchange
    TWO
  • Isin
    TW0004728001
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Biotechnology
  • CEO
  • Headquarter
    Tainan City
  • Web site
    https://www.sunmaxbiotech.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top